Clinical Trials Browser

NETWORK × Breast Neoplasms × Immunohistochemistry × Clear all

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00897299 2017-05-17

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

Breast Neoplasms

NCT00897845 2017-05-17

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

Breast Neoplasms

NCT01156168 2017-05-17

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

Breast Neoplasms, Breast Neoplasms, Male

NCT00753207 2016-02-15

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Phase 1 Completed

Breast Neoplasms

NCT01424865 2015-05-08

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Breast Neoplasms

NCT00949013 2014-05-26

S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313

Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Phase 3 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00899418 2013-04-04

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

Breast Neoplasms